Annpey Pong

1.3k total citations
56 papers, 791 citations indexed

About

Annpey Pong is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Annpey Pong has authored 56 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Molecular Biology and 19 papers in Surgery. Recurrent topics in Annpey Pong's work include Diabetes Treatment and Management (24 papers), Metabolism, Diabetes, and Cancer (18 papers) and Statistical Methods in Clinical Trials (7 papers). Annpey Pong is often cited by papers focused on Diabetes Treatment and Management (24 papers), Metabolism, Diabetes, and Cancer (18 papers) and Statistical Methods in Clinical Trials (7 papers). Annpey Pong collaborates with scholars based in United States, United Kingdom and Canada. Annpey Pong's co-authors include Kelly Parsey, Shein‐Chung Chow, Mark Chang, Robert Frederich, David Z.I. Cherney, Jie Liu, Samuel Dagogo‐Jack, Richard E. Pratley, Mario Maldonado and Francesco Cosentino and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Diabetes.

In The Last Decade

Annpey Pong

55 papers receiving 756 citations

Peers

Countries citing papers authored by Annpey Pong

Since Specialization

Citations

This map shows the geographic impact of Annpey Pong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annpey Pong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annpey Pong more than expected).

Fields of papers citing papers by Annpey Pong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annpey Pong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annpey Pong. The network helps show where Annpey Pong may publish in the future.

Co-authorship network of co-authors of Annpey Pong

This figure shows the co-authorship network connecting the top 25 collaborators of Annpey Pong. A scholar is included among the top collaborators of Annpey Pong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annpey Pong. Annpey Pong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	How many subjects are enough in a veterinary trial?—Literature review and insights from industrial statisticians 2025 ·Research in Veterinary Science ·(unknown), Qi Cao, Qingzhi Liu, (unknown), (unknown), Lih‐Wen Deng, Annpey Pong	2
2	Novel Design and Analysis for Rare Disease Drug Development 2024 ·Mathematics ·Shein Chung Chow, (unknown), Annpey Pong, (unknown), (unknown)	4
3	Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial 2022 ·American Journal of Nephrology ·David Z.I. Cherney, Francesco Cosentino, Samuel Dagogo‐Jack, Darren K. McGuire, Richard E. Pratley, Robert Frederich, Mario Maldonado, Chih‐Chin Liu, Annpey Pong, Christopher P. Cannon, (unknown)	9
4	Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis 2021 ·Osteoporosis International ·Kenneth G. Saag, Felicia Cosman, (unknown), Bente Langdahl, B. B. Scott, Andrew Denker, Annpey Pong, Arthur C. Santora	3
5	Review of current controversial issues in clinical trials 2021 ·General Psychiatry ·Shein‐Chung Chow, (unknown), (unknown), (unknown), Annpey Pong	2
6	Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial 2021 ·Diabetologia ·(unknown), David Z.I. Cherney, B Charbonnel, Francesco Cosentino, Samuel Dagogo‐Jack, Darren K. McGuire, Richard E. Pratley, Weichung Shih, Robert Frederich, Mario Maldonado, Annpey Pong, Christopher P. Cannon	109
7	Mediators of the effect of ertugliflozin on a composite kidney outcome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: analyses from VERTIS CV 2021 ·European Heart Journal ·David Z.I. Cherney, Matthew W. Segar, Ambarish Pandey, Christopher P. Cannon, Francesco Cosentino, Samuel Dagogo‐Jack, Richard E. Pratley, Robert Frederich, Nilo B. Cater, Mario Maldonado, (unknown), (unknown), Annpey Pong, Darren K. McGuire	1
8	Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy regimens: a subgroup analysis from a randomized clinical trial of response in subjects by cancer type 2020 ·BMC Cancer ·(unknown), Karin Jordan, Stuart Green, Saleem Khanani, (unknown), (unknown), Annpey Pong, Stephen J. Noga, Bernardo L. Rapoport	5
9	Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials 2020 ·Diabetologia ·David Z.I. Cherney, Hiddo J.L. Heerspink, Robert Frederich, Mario Maldonado, Jie Liu, Annpey Pong, Zhi Jin Xu, Shrita M. Patel, Anne Hickman, James P. Mancuso, Ira Gantz, Steven G. Terra	33
10	The effects of ertugliflozin on β‐cell function: Pooled analysis from four phase 3 randomized controlled studies 2020 ·Diabetes Obesity and Metabolism ·Silvina Gallo, Annaswamy Raji, Roberto A. Calle, Annpey Pong, Christian Meyer	3
11	Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use? 2019 ·Contraception ·Diana Mansour, Ian S. Fraser, Alison Edelman, Carolina Sales Vieira, Andrew M. Kaunitz, Tjeerd Korver, Annpey Pong, Jianxin Lin, Arvind Shah, Michelle C. Fox, Hans Rekers, Mitchell D. Creinin	11
12	Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials 2019 ·Cardiovascular Diabetology ·Jie Liu, Annpey Pong, Silvina Gallo, Amanda Darekar, Steven G. Terra	18
13	Efficacy and Safety of Ertugliflozin across Racial Groups in Patients with Type 2 Diabetes Mellitus (T2DM) 2018 ·Diabetes ·Jie Liu, Lisa Tarasenko, Annpey Pong, Susan Huyck, (unknown), James P. Mancuso, Steven G. Terra, Brett Lauring	1
14	A Pooled Analysis of the Efficacy and Safety of Ertugliflozin as Add-On Therapy to Metformin 2018 ·Diabetes ·Roberto A. Calle, Jie Liu, Susan Huyck, (unknown), Annpey Pong, James P. Mancuso, Steven G. Terra, Brett Lauring	1
15	A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes 2017 ·Diabetes Research and Clinical Practice ·Philip Home, R. Ravi Shankar, Ira Gantz, (unknown), Edward A. O’Neill, Lokesh Jain, Annpey Pong, Shailaja Suryawanshi, Samuel S. Engel, Keith D. Kaufman, Eseng Lai	12
16	Correlations between 25(OH)D and BMD change in postmenopausal osteoporotic women : secondary analyses of a 1-year trial of weekly alendronate (ALN) plus vitamin D3 5600 IU vs. standard care 2012 ·Open Repository and Bibliography (University of Liège) ·Jean‐Yves Reginster, Neil Binkley, Steven Boonen, Douglas P. Kiel, Stuart H. Ralston, Christian Roux, Annpey Pong, Elizabeth Rosenberg, Arthur C. Santora	1
17	Handbook of Adaptive Designs in Pharmaceutical and Clinical Development 2010 ·Annpey Pong, Shein‐Chung Chow	32
18	Combination oxycodone 5 mg/ibuprofen 400 mg for thetreatment of pain after abdominal or pelvic surgery in women: A randomized, double-blind, placebo- and active-controlled parallel-group study 2005 ·Clinical Therapeutics ·Neil Singla, Annpey Pong, Ken B. Newman	31
19	An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen 2000 ·Contraception ·Kelly Parsey, Annpey Pong	128
20	Comparison of CNS AdverseEffects between Astemizole andChlorpheniramine in Children: ARandomized, Double-Blind Study 1993 ·Developmental Pharmacology and Therapeutics ·A Shanon, William H. Feldman, (unknown), Annpey Pong, Robert G. Peterson, Victoria Williams	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact